Anish John's most recent trade in Oncocyte Corporation was a trade of 121,381 Option to Purchase Common Stock done . Disclosure was reported to the exchange on Feb. 24, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Oncocyte Corporation | Anish John | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 121,381 | 121,381 | - | - | Option to Purchase Common Stock | |
Oncocyte Corporation | Anish John | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 250,466 | 250,466 | - | - | Option to Purchase Common Stock | |
Oncocyte Corporation | Anish John | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 150,000 | 150,000 (0%) | 0% | 0 | Common Stock, no par value | |
Oncocyte Corporation | Anish John | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 100,000 | 100,000 | - | - | Option to Purchase Common Stock | |
Oncocyte Corporation | Anish John | SVP, Finance, and Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock |